Drug Discovery and Development

Drug Discovery and Development is a Masters program taught at Technische Hochschule Köln, Germany. Intake: Fall, Spring. The program is offered in campus-based modes with full-time (1–2 years) options.

Drug Discovery and Development (Master) is a research-oriented Master of Science (M.Sc.) offered jointly by the Universität zu Köln and TH Köln, leading to a shared degree. The programme studies the discovery and development process of medicines using a whole-process, synoptic view, covering the connection between discovery and development rather than focusing only on individual parts such as medical chemistry, pharmacology, regulatory topics, or toxicology.

The programme is a full-time course with a standard study period of 4 semesters and a total workload of 120 ECTS. Teaching is in German and English, and the programme is based at Campus Leverkusen. After successful completion, the route is open for direct entry into pharmaceutical research and development or for a promotion.

The minimum requirements for admission in Drug Discovery and Development at Technische Hochschule Köln for all applicants (Domestic or International) are:

• program specific academic requirment set by Technische Hochschule Köln.
• English Language OR any other language requirments as set by Technische Hochschule Köln as pre-requiste for admission in Drug Discovery and Development.

Note: Please check the university website in the link below.

Please check detail of study units at https://www.th-koeln.de/studium/drug-discovery-and-development-master_30039.php

• Direct entry into pharmaceutical research and development
• Promotion
• Pharmaceutical research and development industry
• Small and medium-sized companies in the health sector (Biotech firms, contract research institutes)
• Authorities such as BfArM
• Authorities such as EMA

72 fully funded scholarships are listed for Germany. See Germany scholarships.